The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene
Abstract
The small packaging capacity of adeno-associated virus (AAV) vectors limits the utility of this promising vector system for transfer of large genes. We explored the possibility that larger genes could be reconstituted following homologous recombination between AAV vectors carrying overlapping gene fragments. An alkaline phosphatase (AP) gene was split between two such AAV vectors (rec vectors) and packaged using AAV2 or AAV6 capsid proteins. Rec vectors having either capsid protein recombined to express AP in cultured cells at about 1-2% of the rate observed for an intact vector. Surprisingly, the AAV6 rec vectors transduced lung cells in mice almost as efficiently as did an intact vector, with 10% of airway epithelial cells, the target for treatment of cystic fibrosis (CF), being positive. Thus AAV rec vectors may be useful for diseases such as CF that require transfer of large genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“simultaneous infection of cells with two vectors containing an overlapping fragment of 440 or 1000 bases of the AP gene could successfully transduce HT-1080 cells, although only at 1-2% efficiency of a vector that expressed AP from a single vector genome. 43”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [43]
In the citing paper
“In vivo , the best overlapping vector pair yielded almost identical transduction of the airway epithelium when compared with the single-genome virus.”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [43]
In the citing paper
“they could detect transduction only with vector pairs that shared either 440or 1000-base regions of homology but not with vector pairs without homology. 43”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [43]
In the citing paper
“Intracellular vector recombination of AAV vectors has been previously described.7”
From Effect of genome size on AAV vector packaging (2010) · cites this paper as [7]
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,102
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 756
Recombinant adeno-associated virus for muscle directed gene therapy
Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E., & Wilson, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-306 · Cited by 654
Kessler, P., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L. A., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Cited by
Sorted by citations
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001
Effect of genome size on AAV vector packaging
Wu, Z., Yang, H., & Colosi, P. (2010) · Molecular Therapy · doi:10.1038/mt.2009.255 · Cited by 1,029
Production and characterization of adeno-associated viral vectors
Grieger, J. C., Choi, V. W., & Samulski, R. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.207 · Cited by 580
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 382
Adeno-Associated Virus Vectorology, Manufacturing, and Clinical Applications
Grieger, J. C., & Samulski, R. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00012-0 · Cited by 199
Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer
Lostal, W., Bartoli, M., Bourg, N., Roudaut, C., Bentaïb, A., Miyake, K., Guerchet, N., Fougerousse, F., McNeil, P., & Richard, I. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq065 · Cited by 173
Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome ≥8.2 kb
Lai, Y., Yue, Y., & Duan, D. (2010) · Molecular Therapy · doi:10.1038/mt.2009.256 · Cited by 166
Ghosh, A., Yue, Y., Lai, Y., & Duan, D. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300322 · Cited by 161
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
Uta Griesenbach, D., & Alton, E. W. F. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.010 · Cited by 164
Treatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155
Sheep retrovirus structural protein induces lung tumours
Wootton, S. K., Halbert, C. L., & Miller, A. D. (2005) · Nature · doi:10.1038/nature03492 · Cited by 146
Self-citationExpressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids
Chamberlain, K., Riyad, J. M., & Weber, T. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.140 · Cited by 141
Dyka, F. M., Boye, S. L., Chiodo, V. A., Hauswirth, W. W., & Boye, S. E. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.212 · Cited by 128
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
Bak, R. O., & Porteus, M. H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.064 · Cited by 124
Barriers to inhaled gene therapy of obstructive lung diseases: A review
Kim, N., Duncan, G. A., Hanes, J. S., & Suk, J. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.031 · Cited by 122
Haridhasapavalan, K. K., Borgohain, M. P., Dey, C., Saha, B., Narayan, G., Kumar, S., & Thummer, R. P. (2018) · Gene · doi:10.1016/j.gene.2018.11.069 · Cited by 117
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
Lopes, V. S., Boye, S. E., Louie, C. M., Boye, S., Dyka, F., Chiodo, V, Fofo, H., Hauswirth, W. W., & Williams, D. S. (2013) · Gene Therapy · doi:10.1038/gt.2013.3 · Cited by 112
Ostedgaard, L. S., Rokhlina, T., Karp, P. H., Lashmit, P., Afione, S., Schmidt, M., Zabner, J., Stinski, M. F., Chiorini, J. A., & Welsh, M. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409845102 · Cited by 105
Ghosh, A., Yue, Y., & Duan, D. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.122 · Cited by 95
Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes.
McClements, M. E., & MacLaren, R. E. (2017) · PubMed · Cited by 111
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
Odom, G. L., Gregorevic, P., & Chamberlain, J. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.007 · Cited by 97
Reich, S. J., Auricchio, A., Hildinger, M., Glover, E., Maguire, A. M., Wilson, J. M., & Bennett, J. (2003) · Human Gene Therapy · doi:10.1089/10430340360464697 · Cited by 96
Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
Odom, G. L., Gregorevic, P., Allen, J. M., & Chamberlain, J. S. (2011) · Molecular Therapy · doi:10.1038/mt.2010.205 · Cited by 95
Self-citationvan Lieshout, L. P., Domm, J. M., Rindler, T. N., Frost, K. L., Sorensen, D. L., Medina, S. J., Booth, S. A., Bridges, J. P., & Wootton, S. K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.04.005 · Cited by 93
Li, Y., Zeng, H., Xu, R., Liu, B., & Li, Z. (2009) · Stem Cells · doi:10.1002/stem.234 · Cited by 85
Li, W., Zhang, L., Johnson, J. S., Wu, Z., Grieger, J. C., Xiao, P., Drouin, L. M., Agbandje‐McKenna, M., Pickles, R. J., & Samulski, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.155 · Cited by 89
Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated Virus
Hirsch, M. L., Agbandje‐McKenna, M., & Samulski, R. J. (2010) · Molecular Therapy · doi:10.1038/mt.2009.280 · Cited by 86
Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors
Hirsch, M. L., Wolf, S., & Samulski, R. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3271-9_2 · Cited by 85
Honaramooz, A., Megee, S. O., Zeng, W., Destrempes, M. M., Overton, S. A., Luo, J., Galantino‐Homer, H. L., Modelski, M. J., Chen, F., Blash, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8935com · Cited by 83
Gene therapy for retinal disease
McClements, M. E., & MacLaren, R. E. (2013) · Translational Research · doi:10.1016/j.trsl.2012.12.007 · Cited by 80
Gene and cell‐mediated therapies for muscular dystrophy
Konieczny, P., Swiderski, K., & Chamberlain, J. S. (2012) · Muscle & Nerve · doi:10.1002/mus.23738 · Cited by 83
Can Adeno-Associated Viral Vectors Deliver Effectively Large Genes?
Tornabene, P., & Trapani, I. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.220 · Cited by 76
Emerging strategies for cell and gene therapy of the muscular dystrophies
Muir, L. A., & Chamberlain, J. S. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001100 · Cited by 75
Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral Vectors
Ghosh, A., Yue, Y., Long, C., Bostick, B., & Duan, D. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300153 · Cited by 73
Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression
Linnerth-Petrik, N. M., Santry, L. A., Petrik, J., & Wootton, S. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094595 · Cited by 74
Ghosh, A., Yue, Y., & Duan, D. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.835 · Cited by 69
New developments in the use of gene therapy to treat Duchenne muscular dystrophy
Jarmin, S., Kymäläinen, H., Popplewell, L. J., & Dickson, G. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866087 · Cited by 69
Design of AAV Vectors for Delivery of Large or Multiple Transgenes
Patel, A., Zhao, J., Duan, D., & Lai, Y. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9139-6_2 · Cited by 67
Oversized AAV Transductifon Is Mediated via a DNA-PKcs-independent, Rad51C-dependent Repair Pathway
Hirsch, M. L., Li, C., Bellon, I., Yin, C., Chavala, S., Pryadkina, M., Richard, I., & Samulski, R. J. (2013) · Molecular Therapy · doi:10.1038/mt.2013.184 · Cited by 62
Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral Vectors
Ghosh, A., Yue, Y., Long, C., Bostick, B., & Duan, D. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300081 · Cited by 65
Song, Y., Lou, H., Boyer, J. L., Limberis, M. P., Vandenberghe, L. H., Hackett, N. R., Leopold, P. L., Wilson, J. M., & Crystal, R. G. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.173 · Cited by 63
AAV Engineering for Improving Tropism to the Central Nervous System
Ghauri, M. S., & Ou, L. (2023) · Biology · doi:10.3390/biology12020186 · Cited by 70
Gene therapy for cystic fibrosis: an example for lung gene therapy
Uta Griesenbach, D., Geddes, D. M., & Alton, E. W. F. W. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302368 · Cited by 57
Viral Aggregation: The Knowns and Unknowns
Pradhan, S., Varsani, A., Leff, C. L., Swanson, C. J., & Hariadi, R. F. (2022) · Viruses · doi:10.3390/v14020438 · Cited by 60
Santry, L. A., Ingrao, J. C., Yu, D. L., de Jong, J. G., van Lieshout, L. P., Wood, G. A., & Wootton, S. K. (2017) · BMC Biotechnology · doi:10.1186/s12896-017-0365-2 · Cited by 61
De, B. P., Heguy, A., Leopold, P. L., Wasif, N., Korst, R. J., Hackett, N. R., & Crystal, R. G. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.022 · Cited by 57
Xu, Z., Yue, Y., Lai, Y., Ye, C., Qiu, J., Pintel, D. J., & Duan, D. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.896 · Cited by 55
Duan, D., Yue, Y., & Engelhardt, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4751-4759.2003 · Cited by 63
Expanding Adeno-associated Viral Vector Capacity: A Tale of Two Vectors
Ghosh, A., & Duan, D. (2007) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2007.10648098 · Cited by 53
Pryadkina, M., Lostal, W., Bourg, N., Charton, K., Roudaut, C., Hirsch, M. L., & Richard, I. (2015) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2015.9 · Cited by 53
Kolesnik, V. V., Nurtdinov, R. F., Oloruntimehin, E. S., Karabelsky, A. V., & Malogolovkin, A. S. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1607 · Cited by 53
Gene delivery systems—gene therapy vectors for cystic fibrosis
Klink, D. T., Schindelhauer, D., Laner, A., Tucker, T. A., Bebok, Z. M., Schwiebert, E. M., Boyd, A., & Scholte, B. J. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.05.042 · Cited by 49
Negrete, A., Esteban, G., & Kotin, R. M. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1030-9 · Cited by 49
van Lieshout, L. P., Soule, G., Sorensen, D., Frost, K. L., He, S., Tierney, K. J., Safronetz, D., Booth, S. A., Kobinger, G., Qiu, X., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix644 · Cited by 48
Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear
Akil, O. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107912 · Cited by 47
Optimizing gene delivery vectors for the treatment of heart disease
Gray, S. J., & Samulski, R. J. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.911 · Cited by 48
Gene Therapy of Inherited Retinal Degenerations: Prospects and Challenges
Trapani, I., Banfi, S., Simonelli, F., Surace, E. M., & Auricchio, A. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.030 · Cited by 46
Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice
Zhou, Y., Zhang, C., Xiao, W., Herzog, R. W., & Han, R. (2024) · Nature Communications · doi:10.1038/s41467-024-50569-6 · Cited by 48
Efficacy of Codelivery of Dual AAV2/5 Vectors in the Murine Retina and Hippocampus
Palfi, A., Chadderton, N., McKee, A. G., Blanco Fernandez, A., Humphries, P., Kenna, P. F., & Farrar, G. J. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.142 · Cited by 42
Halbert, C. L., Lam, S.-L., & Miller, A. D. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.182 · Cited by 43
Self-citationAdvances in AAV-mediated gene transfer for the treatment of inherited disorders
Hildinger, M., & Auricchio, A. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201153 · Cited by 40
György, B., & Maguire, C. A. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1488 · Cited by 44
Dual-AAV delivery of large gene sequences to the inner ear
Reisinger, E. (2020) · Hearing Research · doi:10.1016/j.heares.2019.107857 · Cited by 37
Novel Therapies for the Treatment of Cystic Fibrosis: New Developments in Gene and Stem Cell Therapy
Sueblinvong, V., Suratt, B. T., & Weiss, D. J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.02.004 · Cited by 34
Efficient Production of Dual Recombinant Adeno-Associated Viral Vectors for Factor VIII Delivery
Qizhao, W., Dong, B., Firrman, J., Roberts, S., Moore, A. R., Cao, W., Diao, Y., Kapranov, P., Xu, R., & Xiao, W. (2014) · Human Gene Therapy Methods · doi:10.1089/hgtb.2014.093 · Cited by 35
Halbert, C. L., Metzger, M. J., Lam, S.-L., & Miller, A. D. (2010) · Gene Therapy · doi:10.1038/gt.2010.167 · Cited by 34
Self-citationPergolizzi, R. G., Ropper, A. E., Dragos, R., Reid, A. C., Nakayama, K., Tan, Y., Ehteshami, J. R., Coleman, S. H., Silver, R. B., Hackett, N. R., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.022 · Cited by 35
Nanotherapy for Duchenne muscular dystrophy
Nance, M. E., Hakim, C. H., Yang, N. N., & Duan, D. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1472 · Cited by 35
Cystic fibrosis gene therapy: successes, failures and hopes for the future
Uta Griesenbach, D., & Alton, E. W. F. W. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.25 · Cited by 33
Bisserier, M., Sun, X., Fazal, S., Turnbull, I. C., Bonnet, S., & Hadri, L. (2022) · Cells · doi:10.3390/cells11060984 · Cited by 36
Progress in Respiratory Gene Therapy
McLachlan, G., Alton, E. W. F. W., Boyd, A., Clarke, N. K., Davies, J. C., Gill, D. R., Uta Griesenbach, D., Hickmott, J. W., Hyde, S. C., Miah, K. M., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.172 · Cited by 32
Triggering RNAi with multifunctional RNA nanoparticles and their delivery
Dao, B. N., Viard, M., Martins, A. N., Kasprzak, W. K., Shapiro, B. A., & Afonin, K. A. (2015) · DNA and RNA Nanotechnology · doi:10.1515/rnan-2015-0001 · Cited by 30
Boye, S. E., Huang, W.-C., Román, A. J., Sumaroka, A., Boye, S. L., Ryals, R. C., Olivares, M. B., Ruan, Q., Tucker, B. A., Stone, E. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092928 · Cited by 31
White, A. F., Mazur, M., Sorscher, E. J., Zinn, K. R., & Ponnazhagan, S. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.117 · Cited by 31
AAV Recombineering with Single Strand Oligonucleotides
Hirsch, M. L., Storici, F., Li, C., Choi, V. W., & Samulski, R. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007705 · Cited by 26
Expert opinion in biological therapy: update on developments in lung gene transfer
Uta Griesenbach, D., & Alton, E. W. F. W. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.735656 · Cited by 25
Local Network Topology in Human Protein Interaction Data Predicts Functional Association
Li, H., & Liang, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006410 · Cited by 24
Gene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?
Anson, D. S., Smith, G., & Parsons, D. (2006) · Current Gene Therapy · doi:10.2174/156652306776359496 · Cited by 24
Keswani, S. G., Balaji, S., Le, L. D., Leung, A., Katz, A. B., Lim, F. Y., Habli, M. A., Jones, H. N., Wilson, J. M., & Crombleholme, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043633 · Cited by 25
Yu, D. L., Linnerth-Petrik, N. M., Halbert, C. L., Walsh, S. R., Miller, A. D., & Wootton, S. K. (2011) · Journal of Virology · doi:10.1128/jvi.00400-11 · Cited by 22
Self-citationRevolution of AAV in Drug Discovery: From Delivery System to Clinical Application
Yin, L., He, H., Zhang, H., Shang, Y., Fu, C., Wu, S., & Jin, T. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70447 · Cited by 23
Linnerth-Petrik, N. M., Santry, L. A., Yu, D. L., & Wootton, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051400 · Cited by 23
Pergolizzi, R. G., & Crystal, R. G. (2004) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.05.008 · Cited by 20
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 19
Nitzahn, M., Allegri, G., Khoja, S., Truong, B., Makris, G., Häberle, J., & Lipshutz, G. S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.011 · Cited by 19
LPS-induced bronchial hyperreactivity: interference by mIL-10 differs according to site of delivery
Deleuze, V., Lefort, J., Bureau, M. F., Scherman, D., & Vargaftig, B. B. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00053.2003 · Cited by 18
Large-Scale Production of Recombinant Adeno-Associated Viral Vectors
Negrete, A., & Kotin, R. M. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-237-3_5 · Cited by 18
New Directions in Pulmonary Gene Therapy
Vu, A., & McCray, P. B. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.166 · Cited by 19
Kosaka, M., Sajiki, A. F., Fujita, K., Yamada, K., Kawano, K., Hirazawa, K., Matsuno, T., Takada, M., Shimozawa, N., Inoue, K., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101474 · Cited by 16
Guilleman, M. M., Stevens, B. A. Y., van Lieshout, L. P., Rghei, A. D., Pei, Y., Santry, L. A., Thompson, B., & Wootton, S. K. (2021) · Gene Therapy · doi:10.1038/s41434-021-00236-y · Cited by 14
Viral vectors for cystic fibrosis gene therapy: What does the future hold?
Uta Griesenbach, D., Inoue, Hasegawa, & Alton, E. W. F. W. (2010) · Virus Adaptation and Treatment · doi:10.2147/vaat.s8887 · Cited by 13
Delivering Large Therapeutic Genes for Muscle Gene Therapy
Lai, Y., Yue, Y., Bostick, B., & Duan, D. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_12 · Cited by 11
Maurer, A. C., Benyamini, B., Whitney, O. N., Fan, V. B., Cattoglio, C., Kissiov, D. U., Dailey, G. M., Darzacq, X., Weitzman, M. D., & Tjian, R. (2025) · Nature Communications · doi:10.1038/s41467-025-56738-5 · Cited by 9
Adeno-Associated Viral Gene Therapy for Retinal Disorders
Silva, S. R. D., McClements, M. E., Hankins, M. W., & MacLaren, R. E. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_9 · Cited by 10
Duchenne Cardiomyopathy Gene Therapy
Shin, J., Bostick, B., Fine, D. M., Yue, Y., & Duan, D. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_9 · Cited by 10
Miyake, T., Tanaka, K., Inoue, Y., Nagai, Y., Nishimura, R., Seta, T., Nakagawa, S., Inoue, K., Hasegawa, E., Minamimoto, T., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100881 · Cited by 10
Rghei, A. D., van Lieshout, L. P., McLeod, B. M., Pei, Y., Lopes, J. A., Zielinska, N., Baracuhy, E. M., Stevens, B. A. Y., Thomas, S. P., Yates, J. G. E., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091186 · Cited by 9
AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy
Lin, J., Lin, Y., Liu, N., Cao, W., Zhang, J., Wen, S., Zhang, Y., Liao, W., Hong, Z., Lin, Y., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.039 · Cited by 12
Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy
Dai, L., & Du, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.961848 · Cited by 8
Metadata
- Authors
- Halbert, C. L., Allen, J. M., & Miller, A. D.
- Affiliations
- Fred Hutch Cancer Center (US)
- Corresponding author
- Miller, A. Dusty
- Venue
- Nature Biotechnology
- Published
- 2002-07
- Volume
- 20
- Issue
- 7
- Pages
- 697-701
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2042805311
- Cited by
- 121
- References
- 25
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Earth Sciences
- Ministry of Education, India
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U01HL066947, HL-66947)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-47754, P30DK047754)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- adeno-associated virus vectors, homologous recombination, alkaline phosphatase reporter, airway epithelial cells, cystic fibrosis gene therapy
- MeSH terms
- Dependovirus, Animals, Gene Expression Regulation, Genetic Vectors, Humans, Lung, Mice, Inbred C57BL, Recombination, Genetic, Transduction, Genetic, Respiratory Mucosa, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review